NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
Moore Kuehn is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- American National Bankshares Inc. (NASDAQ: AMNB)
American National Bankshares has agreed to merge with Atlantic Union Bankshares. Under the proposed transaction, AMNB shareholders will receive 1.35 shares of Atlantic Union common stock.
- Sculptor Capital Management Inc. (NYSE: SCU)
Sculptor Capital Management has agreed to merge with Rithm Capital. Under the proposed transaction, Sculptor Capital Management shareholders will receive $11.15 in cash per share.
- Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
Neoleukin Therapeutics has agreed to merge with Neurogene. Under the proposed transaction, Neoleukin Therapeutics shareholders are expected to own approximately 16% of the combined company.
- Pardes Bioscience, Inc. (NASDAQ: PRDS)
Pardes Bioscience has agreed to merge with MediPacific. Under the proposed transaction, Pardes Bioscience shareholders will receive not less than $2.02 in cash and an additional cash amount of not more than $0.17 per share.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245
